The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

In Europe, the introduction of HBV vaccination has markedly reduced the incidence of acute HBV ... [1] Since 1992, the inclusion of hepatitis B vaccination has been recommended by the WHO in ...

Chronic hepatitis B (CHB) remains a significant global health challenge, and effective antiviral therapies are essential for long-term management. This study aimed to evaluate the real-world ...

A Seattle biotech company is working on a tweak to gene expression that could shut down hepatitis B (HBV), one of the viruses ...

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Acute Hepatitis B Virus [Short-term] Chronic Hepatitis B Virus [Long-term] The thing is that there is nothing to worry about when it comes to the short-term version of this virus. Why is that?

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...